MedTrace Logo

A Clinical Study of the Combination of SHR8554 Injection and SHR0410 Injection for the Treatment of Pain After Abdominal Surgery.

NCT05470049 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2022-07-22

No results posted yet for this study

Summary

The primary objective is to evaluate the analgesic efficacy of the combination of SHR8554 injection and SHR0410 injection compared with SHR8554 injection in patients with acute postoperative pain following abdominal surgery

Conditions

Interventions

DRUG

SHR8554 Injection and SHR0410 Injection

Treatment group A: SHR8554 Injection and SHR0410 Injection; high dose

DRUG

SHR8554 Injection and SHR0410 Injection

Treatment group B: SHR8554 Injection and SHR0410 Injection; low dose

DRUG

SHR8554 Injection and Placebo for SHR0410 Injection

Treatment group C: SHR8554 Injection and Placebo for SHR0410 Injection

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2022-11-01
Completion
2022-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05470049 on ClinicalTrials.gov